Vanderbilt Evaluating GE Platform for Insights into Colon Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Vanderbilt University is partnering with GE Global Research to evaluate GE's cancer mapping technology for cellular insight into colon tumors.

The partnership, announced today and supported by a five-year, $3.75 million grant from the Office of the Director of the National Institutes of Health, will test GE's automated platform that can probe and analyze up to 60 different disease biomarkers, including proteins and messenger RNAs, in a single tissue sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.